782
Views
12
CrossRef citations to date
0
Altmetric
Review

Molecular histology of arteries: mass spectrometry imaging as a novel ex vivo tool to investigate atherosclerosis

, , &

References

• A good introductory review for starting experiments in MSI field.

  • Goodwin RJ. Sample preparation for mass spectrometry imaging: small mistakes can lead to big consequences. J Proteomics. 2012;75:4893–4911.
  • McDonnell LA, Heeren RM. Imaging mass spectrometry. Mass Spectrom Rev. 2007;26:606–643.
  • Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem. 1988;60(20):2299–2301.
  • Kaletas BK, Van Der Wiel IM, Stauber J, et al. Sample preparation issues for tissue imaging by imaging MS. Proteomics. 2009;9(10):2622–2633.
  • Addie RD, Balluff B, Bovee JV, et al. Current state and future challenges of mass spectrometry imaging for clinical research. Anal Chem. 2015;87:6426–6433.
  • Angel PM, Caprioli RM. Matrix-assisted laser desorption ionization imaging mass spectrometry: in situ molecular mapping. Biochemistry. 2013;52(22):3818–3828.
  • Caprioli RM. Imaging mass spectrometry: enabling a new age of discovery in biology and medicine through molecular microscopy. J Am Soc Mass Spectrom. 2015;26(6):850–852.
  • Neubert P, Walch A. Current frontiers in clinical research application of MALDI imaging mass spectrometry. Expert Rev Proteomics. 2013;10:259–273.
  • Gessel MM, Norris JL, Caprioli RM. MALDI imaging mass spectrometry: spatial molecular analysis to enable a new age of discovery. J Proteomics. 2014;107:71–82.
  • Barcelo-Coblijn G, Fernandez JA. Mass spectrometry coupled to imaging techniques: the better the view the greater the challenge. Front Physiol. 2015;6:3.
  • Schwamborn K, Caprioli RM. Molecular imaging by mass spectrometry–looking beyond classical histology. Nat Rev Cancer. 2010;10(9):639–646.
  • Hanrieder J, Ljungdahl A, Andersson M. MALDI imaging mass spectrometry of neuropeptides in Parkinson’s disease. J Vis Exp. 2012;(60):pii:3445. doi:10.3791/3445
  • Chatterji B, Dickhut C, Mielke S, et al. MALDI imaging mass spectrometry to investigate endogenous peptides in an animal model of Usher’s disease. Proteomics. 2014;14(13–14):1674–1687.
  • Fernandez JA, Ochoa B, Fresnedo O, et al. Matrix-assisted laser desorption ionization imaging mass spectrometry in lipidomics. Anal Bioanal Chem. 2011;401(1):29–51.
  • Prideaux B, Stoeckli M. Mass spectrometry imaging for drug distribution studies. J Proteomics. 2012;75:4999–5013.
  • Bagnato C, Thumar J, Mayya V, et al. Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics. 2007;6:1088–1102.
  • de la Cuesta F, Alvarez-Llamas G, Maroto AS, et al. A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima. Mol Cell Proteomics. 2011;10:M110.
  • de la Cuesta F, Zubiri I, Maroto AS, et al. Deregulation of smooth muscle cell cytoskeleton within the human atherosclerotic coronary media layer. J Proteomics. 2013;82:155–165.
  • Chaurand P. Imaging mass spectrometry of thin tissue sections: a decade of collective efforts. J Proteomics. 2012;75:4883–4892.
  • Jones EA, Deininger SO, Hogendoorn PC, et al. Imaging mass spectrometry statistical analysis. J Proteomics. 2012;75:4962–4989.
  • Trim PJ, Djidja MC, Muharib T, et al. Instrumentation and software for mass spectrometry imaging–making the most of what you’ve got. J Proteomics. 2012;75:4931–4940.
  • Thomas A, Chaurand P. Advances in tissue section preparation for MALDI imaging MS. Bioanalysis. 2014;6:967–982.
  • Miura D, Fujimura Y, Wariishi H. In situ metabolomic mass spectrometry imaging: recent advances and difficulties. J Proteomics. 2012;75:5052–5060.
  • Berry KA, Hankin JA, Barkley RM, et al. MALDI imaging of lipid biochemistry in tissues by mass spectrometry. Chem Rev. 2011;111:6491–6512.
  • Chaurand P, Cornett DS, Angel PM, et al. From whole-body sections down to cellular level, multiscale imaging of phospholipids by MALDI mass spectrometry. Mol Cell Proteomics. 2011;10:O110.
  • Norris JL, Caprioli RM. Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research. Chem Rev. 2013;113(4):2309–2342.
  • Cillero-Pastor B, Eijkel GB, Kiss A, et al. Matrix-assisted laser desorption ionization-imaging mass spectrometry: a new methodology to study human osteoarthritic cartilage. Arthritis Rheum. 2013;65(3):710–720.
  • Carreira RJ, Shyti R, Balluff B, et al. Large-scale mass spectrometry imaging investigation of consequences of cortical spreading depression in a transgenic mouse model of migraine. J Am Soc Mass Spectrom. 2015;26(6):853–861.
  • Magni F, Lalowski M, Mainini V, et al. Proteomics imaging and the kidney. J Nephrol. 2013;26(3):430–436.
  • Schone C, Hofler H, Walch A. MALDI imaging mass spectrometry in cancer research: combining proteomic profiling and histological evaluation. Clin Biochem. 2013;46(6):539–545.
  • Wisztorski M, Croix D, Macagno E, et al. Molecular MALDI imaging: an emerging technology for neuroscience studies. Dev Neurobiol. 2008;68:845–858.
  • Dekker TJ, Balluff BD, Jones EA, et al. Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma. J Proteome Res. 2014;13:4730–4738.
  • Buck A, Ly A, Balluff B, et al. High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed, paraffin-embedded clinical tissue samples. J Pathol. 2015;237:123–132.

• Metabolites analysis by MSI from FFPE tissues.

  • Aichler M, Elsner M, Ludyga N, et al. Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria. J Pathol. 2013;230(4):410–419.
  • Balluff B, Frese CK, Maier SK, et al. De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry. J Pathol. 2015;235(1):3–13.
  • Reyzer ML, Caldwell RL, Dugger TC, et al. Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res. 2004;64:9093–9100.
  • Mas S, Touboul D, Brunelle A, et al. Lipid cartography of atherosclerotic plaque by cluster-TOF-SIMS imaging. Analyst. 2007;132(1):24–26.
  • Mas S, Martinez-Pinna R, Martin-Ventura JL, et al. Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes. Diabetes. 2010;59:1292–1301.
  • Malmberg P, Borner K, Chen Y, et al. Localization of lipids in the aortic wall with imaging TOF-SIMS. Biochim Biophys Acta. 2007;1771:185–195.
  • Zaima N, Sasaki T, Tanaka H, et al. Imaging mass spectrometry-based histopathologic examination of atherosclerotic lesions. Atherosclerosis. 2011;217:427–432.
  • Lee ES, Shon HK, Lee TG, et al. The regional ratio of cholesteryl palmitate to cholesteryl oleate measured by ToF-SIMS as a key parameter of atherosclerosis. Atherosclerosis. 2013;226:378–384.
  • Bot M, De Jager SC, MacAleese L, et al. Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation. J Lipid Res. 2013;54:1265–1274.
  • Castro-Perez J, Hatcher N, Kofi KN, et al. In vivo isotopically labeled atherosclerotic aorta plaques in ApoE KO mice and molecular profiling by matrix-assisted laser desorption/ionization mass spectrometric imaging. Rapid Commun Mass Spectrom. 2014;28:2471–2479.
  • Lehti S, Sjovall P, Kakela R, et al. Spatial distributions of lipids in atherosclerosis of human coronary arteries studied by time-of-flight secondary ion mass spectrometry. Am J Pathol. 2015;185(5):1216–1233.
  • Martin-Lorenzo M, Balluff B, Maroto AS, et al. Molecular anatomy of ascending aorta in atherosclerosis by MS imaging: specific lipid and protein patterns reflect pathology. J Proteomics. 2015;126:245–251.

•• The first application of MALDI-MSI to investigate protein changes in arterial atherosclerotic tissue.

  • van Hove ER, Smith DF, Fornai L, et al. An alternative paper based tissue washing method for mass spectrometry imaging: localized washing and fragile tissue analysis. J Am Soc Mass Spectrom. 2011;22:1885–1890.
  • Grey AC, Gelasco AK, Section J, et al. Molecular morphology of the chick heart visualized by MALDI imaging mass spectrometry. Anat Rec (Hoboken). 2010;293:821–828.
  • Menger RF, Stutts WL, Anbukumar DS, et al. MALDI mass spectrometric imaging of cardiac tissue following myocardial infarction in a rat coronary artery ligation model. Anal Chem. 2012;84:1117–1125.
  • Wang HY, Wu HW, Tsai PJ, et al. Matrix-assisted laser desorption/ionization mass spectrometry imaging of cardiolipins in rat organ sections. Anal Bioanal Chem. 2014;406:565–575.
  • Fornai L, Angelini A, Klinkert I, et al. Three-dimensional molecular reconstruction of rat heart with mass spectrometry imaging. Anal Bioanal Chem. 2012;404(10):2927–2938.
  • Senyo SE, Steinhauser ML, Pizzimenti CL, et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature. 2013;493(7432):433–436.
  • Thierry B, Winnik FM, Merhi Y, et al. Bioactive coatings of endovascular stents based on polyelectrolyte multilayers. Biomacromolecules. 2003;4(6):1564–1571.
  • Barbucci R, Lamponi S, Magnani A, et al. Role of the Hyal-Cu (II) complex on bovine aortic and lymphatic endothelial cells behavior on microstructured surfaces. Biomacromolecules. 2005;6(1):212–219.
  • Charbonneau C, Liberelle B, Hebert MJ, et al. Stimulation of cell growth and resistance to apoptosis in vascular smooth muscle cells on a chondroitin sulfate/epidermal growth factor coating. Biomaterials. 2011;32:1591–1600.
  • Eun LY, Song H, Choi E, et al. Implanted bone marrow-derived mesenchymal stem cells fail to metabolically stabilize or recover electromechanical function in infarcted hearts. Tissue Cell. 2011;43:238–245.
  • Tanaka H, Zaima N, Ito H, et al. Cilostazol inhibits accumulation of triglycerides in a rat model of carotid artery ligation. J Vasc Surg. 2013;58:1366–1374.
  • Takai S, Jin D, Sakonjo H, et al. Significance of the vascular concentration of angiotensin II-receptor blockers on the mechanism of lowering blood pressure in spontaneously hypertensive rats. J Pharmacol Sci. 2013;123:371–379.
  • Yano K, Takimoto S, Motegi T, et al. Role of P-glycoprotein in regulating cilnidipine distribution to intact and ischemic brain. Drug Metab Pharmacokinet. 2014;29:254–258.
  • Liu Q, Xiao Y, Pagan-Miranda C, et al. Metabolite imaging using matrix-enhanced surface-assisted laser desorption/ionization mass spectrometry (ME-SALDI-MS). J Am Soc Mass Spectrom. 2009;20:80–88.
  • Robichaud G, Barry JA, Garrard KP, et al. Infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI) imaging source coupled to a FT-ICR mass spectrometer. J Am Soc Mass Spectrom. 2013;24:92–100.
  • Jackson SN, Baldwin K, Muller L, et al. Imaging of lipids in rat heart by MALDI-MS with silver nanoparticles. Anal Bioanal Chem. 2014;406:1377–1386.
  • Mainini V, Angel PM, Magni F, et al. Detergent enhancement of on-tissue protein analysis by matrix-assisted laser desorption/ionization imaging mass spectrometry. Rapid Commun Mass Spectrom. 2011;25:199–204.
  • Martin-Lorenzo M, Balluff B, Sanz-Maroto A, et al. 30mum spatial resolution protein MALDI MSI: in-depth comparison of five sample preparation protocols applied to human healthy and atherosclerotic arteries. J Proteomics. 2014;108:465–468.

•• A prognostic signature of gastric cancer was identified by MALDI MSI and further validated by IHC.

•• An update on atherosclerosis development and plaque vulnerability.

  • Rhee EP, Gerszten RE. Metabolomics and cardiovascular biomarker discovery. Clin Chem. 2012;58:139–147.
  • Alvarez-Llamas G, de la Cuesta F, Barderas ME, et al. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective. Expert Rev Proteomics. 2008;5:679–691.
  • de la Cuesta F, Alvarez-Llamas G, Gil-Dones F, et al. Tissue proteomics in atherosclerosis: elucidating the molecular mechanisms of cardiovascular diseases. Expert Rev Proteomics. 2009;6:395–409.
  • Thomas A, Lenglet S, Chaurand P, et al. Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics. Thromb Haemost. 2011;106:20–33.
  • Parry SA, Kurczy ME, Fan X, et al. Imaging macrophages in trehalose with SIMS. Appl Surf Sci. 2008;255:929–933.
  • Frohlich SM, Eilenberg M, Svirkova A, et al. Mass spectrometric imaging of in vivo protein and lipid adsorption on biodegradable vascular replacement systems. Analyst. 2015;140:6089–6099.
  • Cillero-Pastor B, Heeren RM. Matrix-assisted laser desorption ionization mass spectrometry imaging for peptide and protein analyses: a critical review of on-tissue digestion. J Proteome Res. 2014;13(2):325–335.
  • Maier SK, Hahne H, Gholami AM, et al. Comprehensive identification of proteins from MALDI imaging. Mol Cell Proteomics. 2013;12:2901–2910.
  • McDonnell LA, Corthals GL, Willems SM, et al. Peptide and protein imaging mass spectrometry in cancer research. J Proteomics. 2010;73:1921–1944.
  • McDonnell LA, Walch A, Stoeckli M, et al. MSiMass list: a public database of identifications for protein MALDI MS Imaging. J Proteome Res. 2014;13:1138–1142.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.